1. Home
  2. XNET vs INMB Comparison

XNET vs INMB Comparison

Compare XNET & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xunlei Limited

XNET

Xunlei Limited

N/A

Current Price

$3.48

Market Cap

319.3M

Sector

Technology

ML Signal

N/A

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

N/A

Current Price

$1.10

Market Cap

64.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XNET
INMB
Founded
2003
2015
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.3M
64.7M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
XNET
INMB
Price
$3.48
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.00
AVG Volume (30 Days)
263.4K
★ 309.0K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 11.85
EPS
★ N/A
N/A
Revenue
N/A
★ $50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.29
★ N/A
Revenue Growth
N/A
★ 257.14
52 Week Low
$3.10
$1.06
52 Week High
$8.80
$2.60

Technical Indicators

Market Signals
Indicator
XNET
INMB
Relative Strength Index (RSI) 34.49 25.02
Support Level N/A N/A
Resistance Level $6.10 $1.52
Average True Range (ATR) 0.21 0.11
MACD 0.02 -0.02
Stochastic Oscillator 46.02 6.78

Price Performance

Historical Comparison
XNET
INMB

About XNET Xunlei Limited

Xunlei Ltd is a technology company providing distributed cloud services in China. It operates a powerful internet platform in China based on cloud technology to enable its users to quickly access, store, manage and consume digital media content on the internet. The company has expanded its products and services from PC-based devices to mobile devices in part through pre-installed acceleration products in mobile phones to further enlarge its user base and offer its users a wider range of access points. It provides a wide range of products and services across cloud acceleration and digital entertainment to deliver an efficient, smart and safe internet environment to its users.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: